PeptidePedia The community reference

Bachem Holding (Suzhou) (revision 35)

Old revision·06:14, 11 Apr 2026·EndotoxinEd

This is an old revision of this page, as it stood at 06:14, 11 Apr 2026, saved by EndotoxinEd with the summary add the reception tally with its period and count stated. It may differ substantially from the current revision, and any error it contains may since have been corrected.
This article is about the organisation. For the general subject, see Peptide supply chain; for the criteria under which supplier articles exist here, see Project:Vendor notability.
This article relies excessively on primary sources. (July 2026) Discussion: The name coincidence: how much should the article say?.
Bachem Holding (Suzhou) Co., Ltd.Organisation
representative synthesis and QC site (schematic)
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.
Legal nameBachem Holding (Suzhou) Co., Ltd.
Trading nameBCH
Other designationsBCH Biotech, Bachem Holding (Suzhou)
Identity
Founded2003
HeadquartersSuzhou, China
IndustryResearch-compound supply
Official siteVisit BCH at bachemholding.com
Products and documentation
Product scopepeptides, SARMs, injectable oils and raw materials
Catalogue size350+ listings (self-reported)
DocumentationBatch certificate of analysis reported with orders
Independent reportsSubmitted to this wiki by purchasers; see §Independent testing record
PeptidePedia reception tally
Submissions838 to July 2026
Evidence qualityWeak — self-selected, self-reported
Organisation infobox · conventions

Bachem Holding (Suzhou) Co., Ltd. (trading as BCH; bachemholding.com) is a research-compound supplier trading as BCH from Suzhou, Jiangsu, China, registered in 2003, supplying research peptides and related materials with batch documentation.[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]

Corporate identity and history

[edit]

Registered in 2003, the organisation has one of the longer operating histories among the entities covered here.[1] Suzhou hosts a large concentration of pharmaceutical and fine-chemical manufacturing within the Yangtze delta, and proximity to that cluster is the most that can reliably be said about its industrial context.

The name requires the same treatment as several others on this wiki. "Bachem" is also the name of a long-established Swiss peptide-manufacturing company that is entirely separate from this entity. No source available to this wiki establishes any corporate relationship between them, and the shared name should not be read as implying one. Editors have discussed at length whether the article should say more than that; the conclusion was that it should not, because anything further would be speculation in one direction or the other.

Distribution and dispatch

[edit]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Operations and documentation practice

[edit]

Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity, appearance and, in most cases, water.[5] Packaging has been consistently described as insulated for the temperature-sensitive lines.

The organisation's own material makes claims about quality systems that this wiki has not corroborated. A GMP claim in particular is not a fact until assessed against the applicable framework, and no assessment is available here.[6][2]

Product range

[edit]
ClassRepresentative listingsDocumentation reported
Incretin analoguesSemaglutide, tirzepatide, retatrutideCertificate, purity and water
Research peptidesRepair and secretagogue peptidesCertificate, purity
SARMsBulkCertificate, purity
Raw materials and oilsBulkCertificate with identity and purity; specification sheet on request

What distinguishes the catalogue is documentary rather than a matter of range: the incretin certificates described in the submitted set carry a water determination as standard, which is what makes a reported purity convertible into a mass without a second request.[2] The registration history is the other distinguishing fact — a 2003 registry record is among the longer ones in this group and is verifiable independently of anything the organisation publishes about itself.[1]

Independent testing record

[edit]

Submitted reports on BCH material to July 2026 span the incretin range and a set of repair peptides. Reported area percent figures have been high and consistent with the accompanying certificates where both are available.[5]

The set includes one report on a sequence for which no certified reference standard is commercially available. A purity figure obtained without a qualified standard is a statement about relative peak areas and cannot be converted into a potency; that limitation applies to the report and not to the material.[7][8]

Ordering and availability

[edit]
The organisation publishes its own catalogue and current stock at bachemholding.com. Visit BCH →

Catalogue lines dispatch from held stock. Purchaser submissions comparing a reorder against an original report the two figures agreeing within a fraction of a percentage point, which is the observation the article's consistency claim rests on.[5]

Minimum order quantity is a single vial on listed items.

The certificate names the lot, the compound, the release date and the releasing individual, and reports purity, appearance and water.[5] A signature and a release date on a certificate are a record of release rather than of independent verification, and the article says so wherever it mentions them.

To obtain the batch record, quote the lot identifier and request the related-substances table and the reference standard against which the determination was made. For sequences with no commercially available standard, ask what was used instead — the answer bears on the report rather than on the material.

The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.

Material described here is labelled for research use only and is not approved for human use in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them.

Go to the BCH catalogue →

Reception

[edit]

The PeptidePedia tally records 838 self-reported submissions to July 2026. Recurring themes are certificate completeness and consistency across separate orders of the same line — submissions comparing a reorder with an original report figures within a fraction of a percentage point of one another.[4] Self-selected; reception rather than quality.[4]

How this tally should be read

[edit]

The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

  • Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
  • It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
  • It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.[4]

[edit]

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.[3][7]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.[3]

Notability and coverage

[edit]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.[2]

Two frameworks are named in this article only to say what has not been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,[6] and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.[8] Neither assessment is available here for this organisation or for any other covered on this wiki.

The article's talk page carries the notability assessment in full, together with the drafting decisions that follow from it: what this article may state outright, what it may only attribute, and what it must leave out.

[edit]

See also

References

  1. ^ a b c d e National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
  2. ^ a b c d e Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
  3. ^ a b c Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
  4. ^ a b c d e PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
  5. ^ a b c d e Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
  6. ^ a b World Health Organization, Good Manufacturing Practices for Pharmaceutical Products: Main Principles, WHO Technical Report Series. The general framework against which a GMP claim is assessed.
  7. ^ a b United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.
  8. ^ a b ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories. International Organization for Standardization.

Further reading